Review



recombinant human cxcl16  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems recombinant human cxcl16
    RNA-seq and multiplex analyses identify chemokines produced by primary OS samples. A, Expression of 28 chemokines by RNA-seq (FPKM shown; n = 85 OS samples); screen cutoff shown at 1 FPKM. B, Expression of 28 chemokines by protein secretion ( n = 8 patient samples); screen cutoff shown at 3 × 10 3 integrated pixel density. Green bars in A and B denote ligands deemed positive in both RNA and protein screens; error bars indicate SEM. C, Chemokine receptors (ligands in parentheses) CXCR2 (IL8), CXCR3 (CXCL10), CXCR6 <t>(CXCL16),</t> CCR7 (CCL21), and CCR8 (CCL18) as expressed endogenously and detected by flow cytometry on activated T cells ( n = 5 healthy donors; error bars indicate SEM). D, ELISA demonstrating detection of IL8 and CXCL16 in patient transport media specimens ( n = 6 patient tumor samples, 1 normal bone sample; error bars indicate SEM).
    Recombinant Human Cxcl16, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 48 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human cxcl16/product/R&D Systems
    Average 93 stars, based on 48 article reviews
    recombinant human cxcl16 - by Bioz Stars, 2026-03
    93/100 stars

    Images

    1) Product Images from "Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models"

    Article Title: Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models

    Journal: Clinical Cancer Research

    doi: 10.1158/1078-0432.CCR-23-3298

    RNA-seq and multiplex analyses identify chemokines produced by primary OS samples. A, Expression of 28 chemokines by RNA-seq (FPKM shown; n = 85 OS samples); screen cutoff shown at 1 FPKM. B, Expression of 28 chemokines by protein secretion ( n = 8 patient samples); screen cutoff shown at 3 × 10 3 integrated pixel density. Green bars in A and B denote ligands deemed positive in both RNA and protein screens; error bars indicate SEM. C, Chemokine receptors (ligands in parentheses) CXCR2 (IL8), CXCR3 (CXCL10), CXCR6 (CXCL16), CCR7 (CCL21), and CCR8 (CCL18) as expressed endogenously and detected by flow cytometry on activated T cells ( n = 5 healthy donors; error bars indicate SEM). D, ELISA demonstrating detection of IL8 and CXCL16 in patient transport media specimens ( n = 6 patient tumor samples, 1 normal bone sample; error bars indicate SEM).
    Figure Legend Snippet: RNA-seq and multiplex analyses identify chemokines produced by primary OS samples. A, Expression of 28 chemokines by RNA-seq (FPKM shown; n = 85 OS samples); screen cutoff shown at 1 FPKM. B, Expression of 28 chemokines by protein secretion ( n = 8 patient samples); screen cutoff shown at 3 × 10 3 integrated pixel density. Green bars in A and B denote ligands deemed positive in both RNA and protein screens; error bars indicate SEM. C, Chemokine receptors (ligands in parentheses) CXCR2 (IL8), CXCR3 (CXCL10), CXCR6 (CXCL16), CCR7 (CCL21), and CCR8 (CCL18) as expressed endogenously and detected by flow cytometry on activated T cells ( n = 5 healthy donors; error bars indicate SEM). D, ELISA demonstrating detection of IL8 and CXCL16 in patient transport media specimens ( n = 6 patient tumor samples, 1 normal bone sample; error bars indicate SEM).

    Techniques Used: RNA Sequencing Assay, Multiplex Assay, Produced, Expressing, Flow Cytometry, Enzyme-linked Immunosorbent Assay



    Similar Products

    recombinant human cxcl16  (R&D Systems)
    93
    R&D Systems recombinant human cxcl16
    RNA-seq and multiplex analyses identify chemokines produced by primary OS samples. A, Expression of 28 chemokines by RNA-seq (FPKM shown; n = 85 OS samples); screen cutoff shown at 1 FPKM. B, Expression of 28 chemokines by protein secretion ( n = 8 patient samples); screen cutoff shown at 3 × 10 3 integrated pixel density. Green bars in A and B denote ligands deemed positive in both RNA and protein screens; error bars indicate SEM. C, Chemokine receptors (ligands in parentheses) CXCR2 (IL8), CXCR3 (CXCL10), CXCR6 <t>(CXCL16),</t> CCR7 (CCL21), and CCR8 (CCL18) as expressed endogenously and detected by flow cytometry on activated T cells ( n = 5 healthy donors; error bars indicate SEM). D, ELISA demonstrating detection of IL8 and CXCL16 in patient transport media specimens ( n = 6 patient tumor samples, 1 normal bone sample; error bars indicate SEM).
    Recombinant Human Cxcl16, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human cxcl16/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant human cxcl16 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    cxcl16 recombinant protein  (MedChemExpress)
    93
    MedChemExpress cxcl16 recombinant protein
    A Representative flow plots show the frequency of the CXCR6 + CD8 + GZMB + T cells (left) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. B Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells (left) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. C , D Representative flow plots show frequency of the CXCR6 + CD8 + GZMB + T cells ( C ) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells ( D ) in groups with different concentrations of <t>CXCL16</t> recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. E , F Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells ( E ) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells ( F ) in groups with different concentrations of CXCL16 recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. G Representative images of 4NQO-induced HNSCC (upper) and corresponding HE staining(lower) in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 1 mm (upper), 100 μm (lower). H – K Representative images of KI67 ( H ) and Caspase-3 ( J ) IHC staining and quantitation of the percentage of KI67 + ( I ) and Caspase-3 + ( K ) cells in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 50 μm. Data are shown as mean ± SD (n = 8 mice). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. Source data and exact p values are provided as a Source Data file.
    Cxcl16 Recombinant Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cxcl16 recombinant protein/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    cxcl16 recombinant protein - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    human his tagged pd 1 protein  (R&D Systems)
    90
    R&D Systems human his tagged pd 1 protein
    A Representative flow plots show the frequency of the CXCR6 + CD8 + GZMB + T cells (left) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. B Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells (left) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. C , D Representative flow plots show frequency of the CXCR6 + CD8 + GZMB + T cells ( C ) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells ( D ) in groups with different concentrations of <t>CXCL16</t> recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. E , F Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells ( E ) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells ( F ) in groups with different concentrations of CXCL16 recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. G Representative images of 4NQO-induced HNSCC (upper) and corresponding HE staining(lower) in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 1 mm (upper), 100 μm (lower). H – K Representative images of KI67 ( H ) and Caspase-3 ( J ) IHC staining and quantitation of the percentage of KI67 + ( I ) and Caspase-3 + ( K ) cells in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 50 μm. Data are shown as mean ± SD (n = 8 mice). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. Source data and exact p values are provided as a Source Data file.
    Human His Tagged Pd 1 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human his tagged pd 1 protein/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    human his tagged pd 1 protein - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    recombinant human cxcl16 protein  (PeproTech)
    90
    PeproTech recombinant human cxcl16 protein
    ELK3 depletion increases <t>CXCL16</t> expression in TNBC cells.
    Recombinant Human Cxcl16 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human cxcl16 protein/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant human cxcl16 protein - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    976 cx  (R&D Systems)
    93
    R&D Systems 976 cx
    ELK3 depletion increases <t>CXCL16</t> expression in TNBC cells.
    976 Cx, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/976 cx/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    976 cx - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    RNA-seq and multiplex analyses identify chemokines produced by primary OS samples. A, Expression of 28 chemokines by RNA-seq (FPKM shown; n = 85 OS samples); screen cutoff shown at 1 FPKM. B, Expression of 28 chemokines by protein secretion ( n = 8 patient samples); screen cutoff shown at 3 × 10 3 integrated pixel density. Green bars in A and B denote ligands deemed positive in both RNA and protein screens; error bars indicate SEM. C, Chemokine receptors (ligands in parentheses) CXCR2 (IL8), CXCR3 (CXCL10), CXCR6 (CXCL16), CCR7 (CCL21), and CCR8 (CCL18) as expressed endogenously and detected by flow cytometry on activated T cells ( n = 5 healthy donors; error bars indicate SEM). D, ELISA demonstrating detection of IL8 and CXCL16 in patient transport media specimens ( n = 6 patient tumor samples, 1 normal bone sample; error bars indicate SEM).

    Journal: Clinical Cancer Research

    Article Title: Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models

    doi: 10.1158/1078-0432.CCR-23-3298

    Figure Lengend Snippet: RNA-seq and multiplex analyses identify chemokines produced by primary OS samples. A, Expression of 28 chemokines by RNA-seq (FPKM shown; n = 85 OS samples); screen cutoff shown at 1 FPKM. B, Expression of 28 chemokines by protein secretion ( n = 8 patient samples); screen cutoff shown at 3 × 10 3 integrated pixel density. Green bars in A and B denote ligands deemed positive in both RNA and protein screens; error bars indicate SEM. C, Chemokine receptors (ligands in parentheses) CXCR2 (IL8), CXCR3 (CXCL10), CXCR6 (CXCL16), CCR7 (CCL21), and CCR8 (CCL18) as expressed endogenously and detected by flow cytometry on activated T cells ( n = 5 healthy donors; error bars indicate SEM). D, ELISA demonstrating detection of IL8 and CXCL16 in patient transport media specimens ( n = 6 patient tumor samples, 1 normal bone sample; error bars indicate SEM).

    Article Snippet: At time point 0, the transwell was placed into a fresh V-shaped lower-chamber plate with 100 μL of RPMI supplemented with 1% FBS and 0, 10, or 30 ng/mL of recombinant human IL8 (R&D Systems) or recombinant human CXCL16 (R&D Systems).

    Techniques: RNA Sequencing Assay, Multiplex Assay, Produced, Expressing, Flow Cytometry, Enzyme-linked Immunosorbent Assay

    A Representative flow plots show the frequency of the CXCR6 + CD8 + GZMB + T cells (left) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. B Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells (left) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. C , D Representative flow plots show frequency of the CXCR6 + CD8 + GZMB + T cells ( C ) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells ( D ) in groups with different concentrations of CXCL16 recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. E , F Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells ( E ) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells ( F ) in groups with different concentrations of CXCL16 recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. G Representative images of 4NQO-induced HNSCC (upper) and corresponding HE staining(lower) in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 1 mm (upper), 100 μm (lower). H – K Representative images of KI67 ( H ) and Caspase-3 ( J ) IHC staining and quantitation of the percentage of KI67 + ( I ) and Caspase-3 + ( K ) cells in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 50 μm. Data are shown as mean ± SD (n = 8 mice). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. Source data and exact p values are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4 + macrophage infiltration

    doi: 10.1038/s41467-024-51096-0

    Figure Lengend Snippet: A Representative flow plots show the frequency of the CXCR6 + CD8 + GZMB + T cells (left) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. B Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells (left) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells (right) in groups with different PF4 + Macrophage and CD8 + T-cell proportions. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. C , D Representative flow plots show frequency of the CXCR6 + CD8 + GZMB + T cells ( C ) and quantification of the proportions of CXCR6 + CD8 + GZMB + T cells ( D ) in groups with different concentrations of CXCL16 recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. E , F Representative flow plots show the frequency of the CXCR6 + CD8 + PDCD1 + T cells ( E ) and quantification of the proportions of CXCR6 + CD8 + PDCD1 + T cells ( F ) in groups with different concentrations of CXCL16 recombinant protein. Data are shown as mean ± SD (n = 3 biological replicates). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. G Representative images of 4NQO-induced HNSCC (upper) and corresponding HE staining(lower) in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 1 mm (upper), 100 μm (lower). H – K Representative images of KI67 ( H ) and Caspase-3 ( J ) IHC staining and quantitation of the percentage of KI67 + ( I ) and Caspase-3 + ( K ) cells in groups with different concentrations of CXCL16 recombinant protein. Scale bar, 50 μm. Data are shown as mean ± SD (n = 8 mice). P values are presented by one-way ANOVA with Tukey’s multiple comparison test. Source data and exact p values are provided as a Source Data file.

    Article Snippet: In the co-culture system, the Moc1 cells were treated with different proportions of CD8 + T cells and PF4 + Macrophages, or with different concentrations of CXCL16 recombinant protein (HY-P700266, MCE).

    Techniques: Comparison, Recombinant, Staining, Immunohistochemistry, Quantitation Assay

    ELK3 depletion increases CXCL16 expression in TNBC cells.

    Journal: Oncoimmunology

    Article Title: ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer

    doi: 10.1080/2162402X.2023.2190671

    Figure Lengend Snippet: ELK3 depletion increases CXCL16 expression in TNBC cells.

    Article Snippet: Recombinant human CXCL16 protein was purchased from PEPROTECH (300–55, Cranbury, NJ, USA).

    Techniques: Expressing

    The chemotactic activity of CXCL16 recruits NK cells to target TNBC cells.

    Journal: Oncoimmunology

    Article Title: ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer

    doi: 10.1080/2162402X.2023.2190671

    Figure Lengend Snippet: The chemotactic activity of CXCL16 recruits NK cells to target TNBC cells.

    Article Snippet: Recombinant human CXCL16 protein was purchased from PEPROTECH (300–55, Cranbury, NJ, USA).

    Techniques: Activity Assay

    The ELK3-CXCL16 axis determines the response of NK cells in TNBC cells.

    Journal: Oncoimmunology

    Article Title: ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer

    doi: 10.1080/2162402X.2023.2190671

    Figure Lengend Snippet: The ELK3-CXCL16 axis determines the response of NK cells in TNBC cells.

    Article Snippet: Recombinant human CXCL16 protein was purchased from PEPROTECH (300–55, Cranbury, NJ, USA).

    Techniques:

    CXCL16 promotes NK cell chemotaxis and cytotoxicity in vivo .

    Journal: Oncoimmunology

    Article Title: ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer

    doi: 10.1080/2162402X.2023.2190671

    Figure Lengend Snippet: CXCL16 promotes NK cell chemotaxis and cytotoxicity in vivo .

    Article Snippet: Recombinant human CXCL16 protein was purchased from PEPROTECH (300–55, Cranbury, NJ, USA).

    Techniques: Chemotaxis Assay, In Vivo

    Negative correlation between ELK3 and CXCL16 in human breast cancer.

    Journal: Oncoimmunology

    Article Title: ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer

    doi: 10.1080/2162402X.2023.2190671

    Figure Lengend Snippet: Negative correlation between ELK3 and CXCL16 in human breast cancer.

    Article Snippet: Recombinant human CXCL16 protein was purchased from PEPROTECH (300–55, Cranbury, NJ, USA).

    Techniques: